Herbal Monograph
Shatavari
Asparagus racemosus Willd.
Asparagaceae (formerly Liliaceae)
The foremost Ayurvedic women's tonic for lactation, reproductive vitality, and deep nourishment
Overview
Plant Description
Asparagus racemosus is a perennial, woody, climbing or scrambling plant with thorny stems that can reach up to 1-2 meters in height, with some specimens extending to 4 meters when supported. The stems are woody, heavily branched, and covered with recurved spines (modified stipules) that aid in climbing. The true leaves are reduced to minute, triangular scales; the photosynthetic organs are cladodes (modified stems that function as leaves), which are needle-like, flat, linear, and arranged in clusters of 2-6 at each node, measuring 1-3 cm long and approximately 1 mm wide. The plant produces small, fragrant, white flowers in dense racemes (hence the specific epithet 'racemosus'), typically 2-5 cm long, with flowers approximately 3-4 mm in diameter, each with six tepals. Flowers are bisexual, mildly fragrant, and attract pollinators. The fruits are small, spherical berries, 4-6 mm in diameter, green when immature, turning bright red to purplish-red when ripe, each containing 1-2 hard, round, black seeds. The medicinally important part is the tuberous root system, which consists of clusters of 30-100 or more cylindrical, succulent, fusiform (spindle-shaped) tuberous roots arising from a short rootstock. Individual root tubers are 15-45 cm long and 1-3 cm in diameter, tapering at both ends, with a smooth, pale silvery-white to buff exterior when fresh. The tuber flesh is white, mucilaginous, and starchy. The Sanskrit name 'Shatavari' is traditionally interpreted as 'she who possesses a hundred husbands,' alluding to the plant's rejuvenating effects on the female reproductive system, or alternatively referring to the hundred-plus root tubers that emerge from the rootstock.
Habitat
Asparagus racemosus grows naturally in tropical and subtropical regions at elevations from sea level to approximately 1500 meters (4900 feet). It thrives in a variety of habitats including tropical deciduous forests, dry deciduous forests, scrublands, forest margins, and rocky hillsides. The plant prefers well-drained, loamy to sandy soils with moderate fertility, though it is tolerant of a range of soil types including lateritic and rocky substrates. It is drought-tolerant once established, owing to its extensive tuberous root system that stores water and nutrients. It grows in partial shade to full sun, often found scrambling over rocks, fences, and other vegetation at forest edges. Wild populations are found in grasslands, savannas, and secondary forests. The species is increasingly threatened in the wild due to overharvesting for the herbal medicine trade and habitat destruction.
Distribution
Asparagus racemosus has a wide natural distribution across tropical and subtropical Asia and Africa. It is found throughout the Indian subcontinent (India, Nepal, Sri Lanka, Bangladesh), Southeast Asia (Myanmar, Thailand, Malaysia, Indonesia), East Asia (southern China), and extends into tropical and southern Africa (from Ethiopia and East Africa through to South Africa) and northern Australia. India is the primary center of both wild harvest and commercial cultivation, with significant populations in the states of Rajasthan, Gujarat, Maharashtra, Madhya Pradesh, Uttar Pradesh, Karnataka, Kerala, Tamil Nadu, and the Himalayan foothills. The plant has been listed as endangered or vulnerable in several Indian states due to overharvesting, and conservation efforts including cultivation programs have been initiated.
Parts Used
Tuberous root (Shatavari mool)
Preferred: Dried root powder (churna); milk decoction (kshirapaka); standardized aqueous or hydroalcoholic extract
The primary medicinal part used in all traditional systems. The fleshy, cylindrical tuberous roots are the pharmacopeial drug listed in the Ayurvedic Pharmacopoeia of India and WHO Monographs Vol 4. Contains the highest concentrations of steroidal saponins (shatavarins), isoflavones, mucilage, and polysaccharides. Used dried and powdered, or processed with milk (traditional kshirapaka method). The roots are peeled and the central woody core is removed before drying for medicinal use.
Whole plant (aerial parts)
Preferred: Fresh leaf juice; dried leaf powder (limited use)
The leaves, stems, and flowers are used in some regional folk medicine traditions, though they are not the primary pharmacopeial drug. The leaves contain flavonoids and have been studied for antioxidant and antimicrobial activity. The tender young shoots are consumed as a vegetable in some regions. The aerial parts are considered secondary to the tuberous roots in Ayurvedic practice.
Key Constituents
Steroidal saponins (shatavarins and related glycosides)
Steroidal saponins are considered the primary bioactive constituents of Shatavari, responsible for the galactagogue, adaptogenic, immunomodulatory, and female reproductive tonic effects (Negi et al. 2010; Bopana & Saxena 2007). The shatavarins demonstrate phytoestrogenic activity through selective estrogen receptor modulation (competitive binding to estrogen receptors with mild agonist activity), which underlies the herb's traditional use for menopausal symptoms, menstrual irregularities, and lactation support. Saponins also contribute to gastroprotective effects through enhancement of mucosal defensive factors (increased mucus secretion, cytoprotective prostaglandin production). The saponin content serves as the primary quality marker for raw material and extract standardization. Saponins are efficiently extracted by aqueous and hydroalcoholic solvents.
Isoflavones and flavonoids
Isoflavones and flavonoids contribute to the antioxidant, anti-inflammatory, and phytoestrogenic activity of Shatavari. Racemosol in particular is of pharmacological interest for its antifungal and antioxidant properties (Negi et al. 2010). The flavonoid constituents work synergistically with the steroidal saponins to provide the plant's overall therapeutic profile. The isoflavonoid content also supports the traditional use of Shatavari as a female reproductive tonic, as isoflavones are well-characterized phytoestrogens.
Polysaccharides and mucilage
Polysaccharides and mucilage are responsible for the demulcent and gastroprotective actions of Shatavari. The mucilaginous polysaccharides coat and protect irritated mucous membranes of the gastrointestinal and urinary tracts, reducing inflammation and promoting tissue repair. Arabinogalactan polysaccharides contribute to immunostimulatory activity. Prebiotic fructans support healthy gut microbiota, contributing to digestive health and immune function. The mucilage content also enhances the cooling, moistening energetic quality of the root, aligning with its traditional classification as a yin/Pitta-pacifying herb.
Alkaloids
Alkaloid content is low in Shatavari and is not considered a primary driver of therapeutic activity. The trace alkaloid asparagamine A is of research interest for cytotoxic properties but does not significantly contribute to the traditional therapeutic applications at normal doses.
Minerals and trace elements
The mineral content of Shatavari supports its traditional classification as a nutritive Rasayana (rejuvenating tonic). Zinc is particularly relevant to the herb's reproductive health applications, as zinc deficiency is associated with impaired fertility and immune dysfunction. The broad mineral profile contributes to the overall nutritive and tonic quality of the root, particularly when consumed as a whole-root powder preparation.
Other bioactive compounds
Phytosterols, essential fatty acids, and vitamins collectively support the nutritive, anti-inflammatory, and antioxidant actions of Shatavari. These constituents, while individually present at low concentrations, contribute to the synergistic therapeutic profile of the whole root preparation. The phytosterol content adds a mild cholesterol-modulating effect and supports the anti-inflammatory action.
Herbal Actions
Promotes breast milk production
Shatavari is the foremost galactagogue in Ayurvedic medicine. Multiple clinical studies and centuries of traditional use support its ability to enhance breast milk production. Sharma et al. (1996) conducted an RCT demonstrating significant increases in breast milk volume, prolactin levels, and infant weight gain in lactating women taking Shatavari root powder. The galactagogue effect is attributed to the steroidal saponins (shatavarins), which are believed to enhance prolactin secretion and promote mammary gland development. The WHO Monographs Vol 4 lists promotion of lactation as a recognized traditional use supported by clinical evidence.
[1, 3, 4, 5]Helps the body adapt to stress and restore homeostasis
Shatavari is classified as one of the premier adaptogens in Ayurvedic medicine, designated as a Rasayana (rejuvenating tonic) of the highest order. Pandey et al. (2005) demonstrated significant adaptogenic effects in animal models, including enhanced physical endurance, resistance to stress-induced gastric ulceration, normalization of stress-elevated corticosterone levels, and prevention of stress-related immune suppression. The adaptogenic activity is attributed to the combined effects of steroidal saponins, polysaccharides, and antioxidant constituents. As a Rasayana herb, Shatavari is traditionally understood to promote longevity, enhance vitality, improve resistance to disease, and nourish all body tissues (dhatus).
[3, 4, 6, 11]Soothes and protects irritated mucous membranes
The high mucilage and polysaccharide content of Shatavari root produces pronounced demulcent activity, soothing and protecting irritated mucous membranes throughout the gastrointestinal and urinary tracts. The mucilaginous polysaccharides form a protective coating over inflamed mucosal surfaces, reducing irritation and promoting healing. This demulcent action underlies Shatavari's traditional and modern use for peptic ulcer disease, gastritis, irritable bowel syndrome, and urinary tract irritation. The cooling, moistening energetic quality of the root in Ayurvedic classification directly corresponds to this demulcent pharmacological action.
[1, 3, 4]Modulates and balances immune function
Shatavari demonstrates immunomodulatory activity through enhancement of both innate and adaptive immune function. Polysaccharide fractions (arabinogalactans) activate macrophages, increase phagocytic activity, and enhance natural killer cell cytotoxicity. Steroidal saponins stimulate lymphocyte proliferation and enhance antibody production. Preclinical studies have demonstrated increased delayed-type hypersensitivity response, enhanced antibody titers, and improved resistance to infection in animal models. The immunomodulatory activity supports the traditional Rasayana classification of Shatavari as a herb that strengthens the body's resistance to disease.
[3, 4, 6, 8]Prevents or slows oxidative damage to cells
Shatavari extracts demonstrate significant antioxidant activity through multiple mechanisms: direct scavenging of DPPH, superoxide, and hydroxyl free radicals; enhancement of endogenous antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase); inhibition of lipid peroxidation; and chelation of pro-oxidant metal ions. Racemosol and isoflavonoid constituents contribute substantially to the antioxidant capacity. The antioxidant activity supports the adaptogenic, hepatoprotective, and anti-aging (Rasayana) properties of Shatavari.
[3, 4, 10]Reduces inflammation
Shatavari extracts demonstrate anti-inflammatory activity in both acute and chronic inflammation models. Mechanisms include inhibition of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), suppression of COX-2 and lipoxygenase pathways, and reduction of NF-kB activation. In vivo studies show significant reduction of carrageenan-induced paw edema and adjuvant-induced arthritis. The anti-inflammatory action supports the traditional use of Shatavari for inflammatory conditions of the GI tract, reproductive system, and joints.
[3, 4]Supports and calms the nervous system
Shatavari has demonstrated anxiolytic and mild nervine tonic effects in animal models and traditional practice. The root extract has shown GABAergic and serotonergic modulation in preclinical studies. In Ayurvedic tradition, Shatavari is classified as a Medhya Rasayana (brain tonic) that calms Vata (the dosha governing the nervous system), reduces anxiety, and supports mental clarity. The nervine action is gentler than primary nervine herbs but contributes to Shatavari's stress-reducing adaptogenic profile.
[3, 4, 11]Increases urine production and output
Mild diuretic effect documented in traditional use and supported by limited preclinical evidence. The Ayurvedic Pharmacopoeia of India and traditional texts note a mild increase in urinary output. This action, combined with the demulcent and anti-inflammatory properties, supports the traditional use of Shatavari for urinary tract conditions including dysuria and urinary calculi.
[3, 13]Relieves smooth muscle spasm
Shatavari root extract has demonstrated smooth muscle relaxant activity in isolated tissue studies, reducing spontaneous and oxytocin-induced uterine contractions. This antispasmodic action on uterine smooth muscle supports the traditional use for dysmenorrhea and uterine cramps. The mechanism may involve calcium channel modulation and inhibition of prostaglandin synthesis.
[3, 4]Therapeutic Indications
Reproductive System
Insufficient lactation (hypogalactia)
The primary evidence-based indication for Shatavari. Sharma et al. (1996) conducted a double-blind RCT demonstrating significant increases in breast milk volume and prolactin levels compared to placebo. The WHO Monographs Vol 4 recognizes promotion of lactation as a clinically supported use. Multiple traditional systems document galactagogue use spanning centuries. Shatavari root powder (3-6 g daily) or standardized extract is the most widely used herbal galactagogue in Ayurvedic practice.
[1, 3, 5]Menopausal symptoms (vasomotor and psychological)
The phytoestrogenic steroidal saponins (shatavarins) demonstrate selective estrogen receptor binding, providing mild estrogenic support for menopausal women experiencing hot flashes, night sweats, vaginal dryness, mood disturbances, and insomnia. Clinical studies have reported improvements in menopausal symptom scores (Kupperman Index) with Shatavari supplementation. The cooling, moistening energetic quality is particularly appropriate for the hot, dry pattern of menopausal transition. Used traditionally for centuries in Ayurveda as the primary herb for this life stage.
[3, 4, 11]Menstrual irregularities and dysmenorrhea
Shatavari is traditionally used to regulate menstrual cycles, reduce menstrual pain (dysmenorrhea), and address menorrhagia (heavy bleeding). The antispasmodic activity on uterine smooth muscle supports use for painful menstruation. The phytoestrogenic saponins may help normalize hormonal fluctuations underlying irregular cycles. Used in Ayurvedic formulations for menstrual disorders for centuries, often combined with Ashoka bark (Saraca asoca) and Lodhra (Symplocos racemosa).
[3, 11, 13]Female infertility and reproductive tonic
Shatavari is the foremost female reproductive tonic in Ayurveda, used to support fertility, nourish the uterine lining, promote healthy ovulation, and improve cervical mucus quality. The name 'She who possesses a hundred husbands' reflects this traditional association with female fertility and sexual vitality. The adaptogenic, phytoestrogenic, and nutritive properties collectively support reproductive health. Limited clinical trial data specifically for fertility outcomes, but extensive traditional use and supportive preclinical evidence.
[3, 4, 11]Male reproductive health (oligospermia, low libido)
Though primarily known as a women's herb, Shatavari is also used in Ayurveda as a male reproductive tonic (Vajikara) for conditions including oligospermia, low libido, and sexual debility. Animal studies have demonstrated improvements in sperm count, motility, and testosterone levels with Shatavari supplementation. The adaptogenic and antioxidant properties may protect spermatozoa from oxidative damage. Clinical trial evidence in men is limited.
[3, 4, 11]Digestive System
Peptic ulcer disease and gastritis
Shatavari demonstrates potent gastroprotective activity in multiple animal models of gastric ulceration (ethanol-induced, aspirin-induced, pylorus-ligation-induced, and stress-induced ulcer models). The mechanism involves enhancement of mucosal defensive factors: increased gastric mucus secretion, cytoprotective prostaglandin (PGE2) production, decreased gastric acid output, and antioxidant protection of the gastric mucosa. The gastroprotective effect has been found comparable to ranitidine in some preclinical models. The demulcent mucilage provides additional physical protection of the gastric mucosa. The WHO Monographs Vol 4 recognizes gastroprotective use as clinically supported.
[1, 3, 4]Dyspepsia and hyperacidity
Traditional use for acid indigestion, heartburn, and dyspeptic symptoms is well documented in Ayurveda. Shatavari's cooling, demulcent properties soothe inflamed gastric and esophageal mucosa, while the gastroprotective saponins reduce gastric acid secretion. The sweet, cooling taste and Pitta-pacifying quality make Shatavari particularly appropriate for hyperacidity in the Ayurvedic framework.
[3, 11, 13]Inflammatory bowel conditions and diarrhea
The demulcent and anti-inflammatory properties of Shatavari support its traditional use for inflammatory conditions of the lower bowel, including dysentery, diarrhea, and irritable bowel syndrome. The mucilaginous polysaccharides soothe inflamed intestinal mucosa, while the prebiotic fructans support healthy gut microbiota. Limited modern clinical data specific to IBD, but the pharmacological rationale is sound.
[3, 4, 11]Immune System
Immune deficiency and recurrent infections
Shatavari polysaccharides and saponins enhance both innate and adaptive immune function. Preclinical studies demonstrate increased macrophage phagocytic activity, enhanced NK cell cytotoxicity, elevated antibody titers, and improved delayed-type hypersensitivity response. The immunomodulatory activity supports the traditional Rasayana use of Shatavari as a tonic that strengthens host defense mechanisms against infection and disease.
[3, 4, 6]Convalescence and post-illness recovery
Shatavari is a premier convalescence tonic in Ayurveda, used to rebuild strength, nourish depleted tissues, restore vitality, and support immune recovery after illness, surgery, or childbirth. The nutritive, adaptogenic, and immunomodulating properties collectively support recovery. The cooling, nourishing quality is particularly appropriate for recovery from febrile illness where tissues are depleted and dried.
[3, 11]Respiratory System
Dry, irritable cough and bronchitis
The demulcent mucilage soothes dry, irritated respiratory mucous membranes, while the anti-inflammatory properties reduce airway inflammation. Traditional use in Ayurveda for dry cough (Shushka Kasa), sore throat, and bronchial irritation. The cooling, moistening energetic quality is specifically indicated for dry, hot respiratory conditions -- the pattern of dry, hacking cough aggravated by dryness and heat.
[3, 11, 13]Urinary System
Urinary tract irritation and dysuria
Shatavari's demulcent, anti-inflammatory, and mild diuretic properties support its traditional use for burning urination (dysuria), urinary tract infections, and urinary calculi. The mucilaginous polysaccharides soothe inflamed urinary epithelium. Used in Ayurvedic formulations for Mutrakrichra (dysuria) and Ashmari (urinary stones), often combined with Gokshura (Tribulus terrestris) and Punarnava (Boerhavia diffusa).
[3, 11, 13]Endocrine System
Hormonal imbalance and endocrine support
Shatavari's phytoestrogenic saponins modulate estrogen receptor activity and may support overall hormonal balance in conditions of estrogen deficiency. The adaptogenic properties support healthy HPA axis function and stress hormone regulation. Used traditionally as a Rasayana for endocrine support across the female lifespan from menarche through menopause. The complex phytochemistry acts as a hormonal modulator rather than a direct hormone replacement.
[3, 4, 11]Blood sugar regulation (adjunctive)
Preclinical studies have demonstrated hypoglycemic activity of Shatavari root extracts in diabetic animal models. Mechanisms include enhanced insulin secretion, improved insulin sensitivity, and inhibition of carbohydrate-digesting enzymes. The antioxidant properties protect pancreatic beta cells from oxidative damage. Clinical evidence in humans is limited and preliminary.
[3, 4]Nervous System
Stress, anxiety, and nervous exhaustion
Shatavari's adaptogenic and mild nervine properties support its traditional use for stress-related anxiety, nervous debility, and mental fatigue. The Ayurvedic classification as a Medhya Rasayana (brain tonic) supports use for cognitive support and mental clarity. Preclinical studies demonstrate anxiolytic and antidepressant-like effects. The cooling, nourishing quality calms Vata-type nervous agitation characterized by anxiety, restlessness, and insomnia. Often combined with Ashwagandha (Withania somnifera) and Brahmi (Bacopa monnieri) for comprehensive nervous system support.
[3, 4, 11]Hepatobiliary System
Hepatoprotection and liver support
Shatavari root extracts have demonstrated hepatoprotective effects in animal models of hepatotoxicity (CCl4-induced, paracetamol-induced). The mechanism involves enhancement of hepatic antioxidant enzymes, reduction of lipid peroxidation, and modulation of hepatic inflammatory markers. The antioxidant and anti-inflammatory constituents (racemosol, saponins, flavonoids) contribute to liver-protective effects. Clinical data in humans is limited.
[3, 4]Energetics
Temperature
cool
Moisture
moist
Taste
Tissue States
hot/excitation, dry/atrophy, wind/tension
In Ayurvedic classification, Shatavari is Madhura (sweet) and Tikta (bitter) in Rasa (taste), Madhura in Vipaka (post-digestive taste), and Sheeta (cool) in Virya (potency). It pacifies Vata and Pitta doshas while potentially aggravating Kapha in excess due to its heavy, oily, and moistening qualities. In Western herbal energetics, Shatavari is cool and moist -- a deeply nourishing, tissue-building herb that addresses hot, dry, and depleted tissue states. The sweet taste reflects its nourishing, anabolic, tissue-building quality (Rasayana), while the bitter taste provides a mild cleansing and liver-supporting action. Shatavari is the archetype of a 'yin tonic' in cross-system comparison: it restores fluids, cools inflammation, nourishes depleted tissues, and soothes irritated mucous membranes. It is specifically indicated for constitutions or conditions characterized by excess heat, dryness, depletion, and nervous tension -- making it a primary herb for the hot/dry/depleted pattern so common in menopausal and postpartum women, in chronic stress states, and in inflammatory conditions with tissue wasting. CAVEAT: Herbal energetics are interpretive frameworks within Ayurveda and Western herbalism, not standardized across all practitioners.
Traditional Uses
Ayurveda (classical texts: Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya)
- Classified as one of the most important Rasayana (rejuvenating tonic) herbs, promoting longevity, vitality, and resistance to disease
- Premier female reproductive tonic (Stri Rasayana): fertility support, menstrual regulation, menopausal symptom relief, and postpartum recovery
- Foremost galactagogue (Stanyajanana): promoting breast milk production in nursing mothers
- Vajikara (aphrodisiac): enhancing sexual vitality in both women and men
- Shukrala: promoting healthy reproductive tissues and fluids (shukra dhatu)
- Pitta-pacifying: cooling inflammation, reducing hyperacidity, treating burning sensations throughout the body
- Balya (strength-promoting): rebuilding strength during convalescence, debility, and chronic fatigue
- Medhya Rasayana: supporting cognitive function, memory, and mental clarity
- Mutrala: mild diuretic for urinary complaints including dysuria and urinary stones
- Shothahara: reducing swelling and inflammation
"The Charaka Samhita (ca. 300 BCE - 200 CE) lists Shatavari as the foremost herb in the categories of Balya (strength-promoting), Vayasthapana (age-maintaining), and Stanyajanana (galactagogue). Charaka states: 'Shatavari is the best among rejuvenative herbs for women. It promotes strength, improves digestion, and nourishes all seven dhatus (body tissues).' The Sushruta Samhita describes Shatavari as 'cooling, nutritive, aphrodisiac, and beneficial in bleeding disorders, diseases of the female reproductive system, and as a general tonic.' Bhavaprakasha Nighantu classifies it under Guduchyadi Varga and notes its properties: sweet and bitter taste, cool potency, sweet post-digestive effect, unctuous, heavy, Vata and Pitta pacifying."
Siddha medicine (South Indian traditional medicine)
- Known as Thanneervittan Kilangu in Tamil
- Used as a cooling, nutritive tonic for debility and convalescence
- Female reproductive support including menstrual disorders and postpartum care
- Treatment of peptic ulcers and inflammatory bowel conditions
- Used in preparations for urinary tract disorders and kidney stones
- Aphrodisiac and vitality-enhancing preparations
"In the Siddha medical tradition of South India, Shatavari (Thanneervittan Kilangu) is classified as a cooling, nutritive, demulcent herb used extensively in formulations for female reproductive health, digestive disorders, and as a general rejuvenative. Siddha pharmacology describes it as sweet in taste, cooling in potency, and nourishing to the body tissues."
Unani medicine (Greco-Islamic traditional medicine in India)
- Known as Shakakul in Unani medicine
- Classified as having cold and moist temperament (Mizaj)
- Used as a nervine tonic for debility and weakness
- Treatment of dry cough and respiratory dryness
- Female reproductive complaints including menstrual disorders
- Demulcent for gastrointestinal inflammation
- Diuretic for urinary disorders
"In Unani medicine (the Greco-Islamic medical tradition practiced in the Indian subcontinent), Shatavari is known as Shakakul and classified as having a cold and moist temperament. Unani physicians use it as a demulcent, nutritive tonic, and diuretic, with particular emphasis on its cooling and moistening properties for conditions of excessive heat and dryness -- a classification remarkably consistent with its Ayurvedic energetics."
African traditional medicine
- Root decoction used as a remedy for dysentery and diarrhea across East and Southern African cultures
- Galactagogue use in lactating women
- Treatment of sexually transmitted diseases
- General tonic for debility and wasting conditions
- Deworming agent (anthelmintic use)
- Treatment of tuberculosis and chronic respiratory conditions (in some regional traditions)
"In African traditional medicine, Asparagus racemosus (where it occurs naturally in East and Southern Africa) is used in ways that parallel its Ayurvedic applications. Root decoctions are used for digestive complaints, as a galactagogue, and as a general tonic. Several African ethnic groups use it for sexually transmitted infections and as a remedy for intestinal parasites."
[3]
Modern Research
Comprehensive review of Asparagus racemosus pharmacology and therapeutics
A comprehensive narrative review by Alok et al. (2013) covering the phytochemistry, pharmacological activities, and therapeutic applications of Asparagus racemosus. Synthesizes evidence from preclinical and clinical studies across multiple therapeutic domains.
Findings: Documented extensive pharmacological evidence supporting traditional uses: galactagogue activity (enhanced prolactin secretion, increased breast milk volume), adaptogenic effects (enhanced stress resistance, normalized stress hormone levels), immunomodulatory activity (enhanced macrophage phagocytosis, NK cell activity, antibody production), gastroprotective effects (increased gastric mucus, cytoprotective prostaglandins, reduced acid output), antioxidant activity (free radical scavenging, enhanced antioxidant enzymes), anti-inflammatory effects (COX-2 and LOX inhibition, cytokine modulation), and hormonal modulation (phytoestrogenic saponin binding to estrogen receptors). The review identified steroidal saponins (shatavarins I-IV) as the primary bioactive constituents responsible for most pharmacological effects.
Limitations: Narrative review without formal systematic review methodology or meta-analytical quality assessment. Many cited pharmacological studies were preclinical (in vitro and animal models). Clinical trial evidence, while supportive, was limited in volume and methodological rigor. Heterogeneity of extract preparations across studies limits direct comparison.
[4]
Asparagus racemosus: comprehensive review of phytochemistry and pharmacology
Bopana and Saxena (2007) published a comprehensive review integrating phytochemical analysis, traditional use documentation, and modern pharmacological evidence for A. racemosus, with emphasis on reproductive, gastroprotective, and adaptogenic applications.
Findings: Identified and characterized the major phytochemical classes: steroidal saponins (shatavarins I-IV, asparanins), isoflavonoids (racemosol), polysaccharides, alkaloids (asparagamine A), and mucilage. Documented pharmacological evidence for: galactagogue activity (clinical and preclinical), uterine tonic effects (antispasmodic on uterine smooth muscle), phytoestrogenic activity (estrogen receptor binding of saponins), gastroprotective effects (comparable to ranitidine in animal models), adaptogenic activity (enhanced stress tolerance, HPA axis modulation), immunomodulatory effects (enhanced macrophage and NK cell function), and antioxidant activity (significant DPPH and superoxide scavenging). The review noted that A. racemosus is one of the most extensively validated Ayurvedic herbs, with modern pharmacology strongly supporting traditional indications.
Limitations: Narrative review format. Some pharmacological studies cited used crude extracts without standardization, making dose comparisons difficult. Limited number of well-designed RCTs available at time of publication. Mechanism of galactagogue action not fully elucidated.
[3]
Galactagogue effect of Shatavari in lactating women
Sharma et al. (1996) conducted a double-blind, randomized, placebo-controlled trial evaluating the galactagogue efficacy of Shatavari root powder in lactating mothers with insufficient milk production.
Findings: Lactating mothers receiving Shatavari root powder (approximately 60 mg/kg body weight daily) for 30 days showed significant increases in breast milk volume compared to placebo. Prolactin levels were significantly elevated in the treatment group, providing a hormonal mechanism for the galactagogue effect. Infant weight gain was significantly greater in the Shatavari group, confirming clinically meaningful increases in milk production. No adverse effects were reported in mothers or infants. The study provided clinical validation of the traditional Ayurvedic use of Shatavari as a galactagogue.
Limitations: Relatively small sample size. Single-center study conducted in India. Short intervention period (30 days). Specific dose and preparation may not represent all commercial Shatavari products. Breast milk volume measurement methodology may have introduced variability. Limited to women with established lactation insufficiency.
[5]
Adaptogenic and anti-stress activity of Asparagus racemosus
Pandey et al. (2005) investigated the adaptogenic properties of Asparagus racemosus root extract in experimental stress models, evaluating effects on physical endurance, stress-induced gastric ulceration, and immune function under stress conditions.
Findings: A. racemosus root extract demonstrated significant adaptogenic activity: (1) Enhanced swimming endurance time in forced-swim stress model. (2) Significant protection against stress-induced gastric ulceration in cold-restraint stress model, comparable to diazepam. (3) Normalized stress-elevated corticosterone levels, indicating HPA axis modulation. (4) Prevented stress-induced immunosuppression, maintaining antibody titers and cell-mediated immune responses under stress conditions. (5) Demonstrated significant antioxidant activity, reducing stress-induced lipid peroxidation and maintaining glutathione levels. These findings validate the Ayurvedic classification of Shatavari as a Rasayana (adaptogenic tonic) with both physical and mental stress-protective properties.
Limitations: Animal study (rats); direct translation to human clinical outcomes requires human trials. Specific extract preparation and dosing may not correspond to all commercial products. Single-species animal model. Mechanism of adaptogenic action not fully elucidated -- likely involves multiple pathways including HPA axis modulation, antioxidant defense, and immunomodulation.
[6]
Gastroprotective activity of Asparagus racemosus root
Multiple preclinical studies have evaluated the gastroprotective effects of A. racemosus root extract in various experimental ulcer models, demonstrating significant mucosal protection through enhancement of defensive factors.
Findings: A. racemosus root extract demonstrated dose-dependent gastroprotective activity across multiple ulcer models: ethanol-induced, aspirin-induced, pylorus-ligation-induced, and cold-restraint stress-induced gastric ulceration. The protective mechanism involves: (1) Increased gastric mucus secretion and strengthened mucosal barrier. (2) Enhanced cytoprotective prostaglandin (PGE2) production. (3) Significant antioxidant protection of gastric mucosa (reduced lipid peroxidation, enhanced SOD and catalase). (4) Reduced gastric acid output and total acidity. (5) The gastroprotective effect was comparable to ranitidine (standard H2-receptor antagonist) in some models. The mucilage and saponin fractions contributed synergistically to mucosal protection.
Limitations: Preclinical (animal model) evidence. Multiple separate studies with varying extract preparations and doses. Direct extrapolation to human peptic ulcer disease requires clinical validation. Specific contribution of individual constituents (saponins vs mucilage vs polysaccharides) to the overall gastroprotective effect is not fully delineated.
Immunomodulatory activity of Asparagus racemosus
Investigation of the effects of A. racemosus root extract on innate and adaptive immune parameters in animal models, evaluating macrophage activity, antibody responses, and cell-mediated immunity.
Findings: A. racemosus root extract significantly enhanced multiple immune parameters: (1) Increased macrophage phagocytic activity and nitric oxide production. (2) Enhanced antibody (IgG and IgM) titers in response to immunization. (3) Increased delayed-type hypersensitivity response, indicating enhanced cell-mediated immunity. (4) Enhanced natural killer cell cytotoxicity. (5) Increased splenic lymphocyte proliferation in response to mitogens. The polysaccharide fraction (arabinogalactans) was identified as the primary immunostimulatory component, with saponins providing additional immunomodulatory support. These findings support the traditional Rasayana classification of Shatavari as an herb that strengthens the body's defense mechanisms.
Limitations: Animal study data. Immune parameter changes do not directly demonstrate clinical infection resistance in humans. Extract preparation and dosing varied across studies. The balance between immunostimulatory and immunomodulatory effects in different clinical contexts requires further investigation.
Antioxidant activity and free radical scavenging properties
In vitro and in vivo studies evaluating the antioxidant capacity of A. racemosus root extracts, assessing both direct radical scavenging and enhancement of endogenous antioxidant enzyme systems.
Findings: A. racemosus root extracts demonstrated significant antioxidant activity: (1) Strong DPPH free radical scavenging (IC50 comparable to standard antioxidants). (2) Superoxide and hydroxyl radical scavenging activity. (3) Significant inhibition of lipid peroxidation (TBARS reduction) in tissue homogenates. (4) Enhancement of endogenous antioxidant enzymes (SOD, CAT, GPx, GR) in vivo. (5) Prevention of oxidative stress-induced tissue damage in liver, kidney, and brain tissue models. The racemosol and flavonoid constituents were identified as primary contributors to antioxidant activity, with saponins providing secondary antioxidant support. The antioxidant activity supports the adaptogenic, hepatoprotective, and anti-aging (Rasayana) properties.
Limitations: In vitro antioxidant assays do not directly predict in vivo clinical antioxidant benefit. Antioxidant capacity varies with extract preparation method and concentration. Bioavailability of polyphenolic antioxidants after oral administration requires further characterization.
Phytoestrogenic activity and estrogen receptor binding
Investigation of the estrogenic activity of A. racemosus saponins and their interaction with estrogen receptors, providing a mechanistic basis for the herb's traditional use in female reproductive health.
Findings: Steroidal saponins (shatavarins) from A. racemosus demonstrated competitive binding to estrogen receptors (ER-alpha and ER-beta) in receptor binding assays. The binding affinity was considerably lower than 17-beta-estradiol (endogenous estrogen) but sufficient to produce mild estrogenic effects in estrogen-responsive tissues. In uterotrophic assays, A. racemosus extract demonstrated mild estrogenic activity (uterine weight increase) in ovariectomized animals, confirming in vivo phytoestrogenic effects. The phytoestrogenic activity was attributed primarily to shatavarin IV and related spirostanol saponins. This selective, mild estrogenic activity provides a mechanistic basis for the traditional use in menopausal symptoms, menstrual irregularities, and female reproductive tonic applications.
Limitations: In vitro receptor binding and in vivo animal uterotrophic data. The clinical significance of this level of phytoestrogenic activity for menopausal symptom relief in humans requires confirmation in adequately powered RCTs. The safety profile in estrogen-sensitive conditions (breast cancer, endometriosis, fibroids) remains inadequately characterized. Comparison with established phytoestrogens (soy isoflavones, red clover) would be informative.
Anti-diabetic and hypoglycemic activity
Preclinical investigation of the blood glucose-lowering effects of A. racemosus root extract in diabetic animal models, evaluating multiple mechanisms of action.
Findings: A. racemosus root extract demonstrated significant hypoglycemic activity in alloxan- and streptozotocin-induced diabetic rats: (1) Dose-dependent reduction of fasting blood glucose levels. (2) Improved glucose tolerance in oral glucose tolerance tests. (3) Enhanced insulin secretion from pancreatic beta cells. (4) Inhibition of alpha-glucosidase and alpha-amylase (carbohydrate-digesting enzymes), reducing postprandial glucose absorption. (5) Antioxidant protection of pancreatic beta cells from oxidative damage. (6) Partial restoration of pancreatic islet cell architecture in histological analysis. The hypoglycemic activity suggests potential for Shatavari as an adjunctive agent in type 2 diabetes management.
Limitations: Animal study data only. No published human RCTs specifically evaluating Shatavari for diabetes management. Dose translation from animal to human requires careful pharmacokinetic consideration. The degree of blood glucose reduction may not be clinically sufficient as monotherapy. Interaction with conventional antidiabetic medications requires investigation.
Anti-tumor and cytotoxic activity
In vitro investigation of the cytotoxic properties of A. racemosus constituents against human cancer cell lines, evaluating racemofuran (asparagamine A), racemosol, and saponin fractions.
Findings: Multiple constituents of A. racemosus demonstrated cytotoxic activity against human cancer cell lines: (1) Racemofuran (asparagamine A) showed significant cytotoxicity against human colon (HCT-116) and breast (MCF-7) cancer cell lines, with IC50 values in the low micromolar range. (2) Racemosol demonstrated antiproliferative activity against multiple cancer cell lines. (3) Crude saponin fractions showed moderate cytotoxicity against liver and cervical cancer cell lines. (4) The mechanisms involved induction of apoptosis, cell cycle arrest, and inhibition of NF-kB signaling. These findings provide preliminary evidence for anti-tumor potential, though clinical translation is at an early stage.
Limitations: In vitro data only; cytotoxicity against cancer cell lines does not predict clinical anti-cancer efficacy. Concentrations showing cytotoxicity may not be achievable through oral consumption of Shatavari preparations. No clinical trials evaluating Shatavari for cancer treatment have been conducted. Shatavari should not be presented as a cancer treatment.
Preparations & Dosage
Capsule / Powder
Strength: Crude powder: 500 mg per capsule. Standardized extracts: varies by manufacturer, typically 4:1 to 10:1 concentration ratio, standardized to 20-40% saponins
Dried Shatavari root is washed, peeled, cored (central pith removed), dried at 45-55 degrees C, and ground to a fine powder (mesh 60-80). The powder is filled into vegetarian or gelatin capsules, typically 500 mg per capsule. The traditional Ayurvedic method of administering Shatavari churna (powder) mixed with warm milk and honey remains the preferred method, but capsules offer convenience for modern use.
1-2 g dried root powder daily (2-4 capsules of 500 mg) in divided doses. Standardized extracts: follow manufacturer guidelines, typically 500-1000 mg daily.
Twice daily, preferably with meals or with warm milk
May be used long-term as a daily tonic (Rasayana). Traditional use supports extended daily consumption for months to years. Reassess therapeutic need periodically.
Not well established. For children over 6 years: half adult dose under practitioner guidance. Traditionally administered as a milk decoction for children.
Capsules of Shatavari root powder are the most convenient modern preparation. For optimal absorption and in keeping with Ayurvedic tradition, the powder may be opened from capsules and mixed with warm milk (the traditional Anupana or carrier vehicle for Shatavari). The Ayurvedic Pharmacopoeia of India specifies quality standards for Shatavari churna (powder). Products should specify whether they contain crude root powder or a standardized extract, and should be tested for saponin content (minimum shatavarin markers) and absence of heavy metals.
Decoction
Strength: 3-6 g dried root per 250-500 mL liquid (milk or water); traditional milk decoction uses equal parts milk and water, reduced by half
Traditional Shatavari Kshirapaka (milk decoction): Combine 3-6 g of dried, peeled Shatavari root pieces or coarse powder with 250 mL of milk and 250 mL of water. Bring to a gentle boil, then simmer on low heat until the water has evaporated and only the milk remains (approximately 20-30 minutes). Strain and drink warm. Alternatively, a simple water decoction can be prepared by simmering 3-6 g of dried root in 500 mL water for 15-20 minutes, then straining.
3-6 g dried root per dose, decocted in milk or water. 1-2 cups daily.
1-2 times daily, morning and/or evening
May be used long-term. Traditional Rasayana usage recommends extended daily consumption.
Half adult dose for children over 6 years, prepared as milk decoction. Traditionally given to children from early age as a nutritive tonic.
The milk decoction (Kshirapaka) is the most traditional and preferred method of preparing Shatavari in Ayurveda. Milk is considered the ideal Anupana (carrier vehicle) for Shatavari because: (1) milk enhances the absorption of fat-soluble saponins, (2) the sweet, cooling, nutritive quality of milk synergizes with Shatavari's properties, and (3) the combination is traditionally considered the supreme preparation for nourishing female reproductive tissues. For individuals who do not consume dairy, coconut milk or almond milk can be substituted. Honey (added once the decoction has cooled below 40 degrees C) and ghee may be added for additional therapeutic benefit.
Tincture
Strength: 1:5, 45-55% ethanol (dried root). Some practitioners prefer 1:3 for a more concentrated preparation.
Use dried, finely chopped or coarsely powdered Shatavari root. Standard maceration: 1:5 ratio in 45-55% ethanol. Macerate for 4-6 weeks with daily agitation. Press and filter through muslin and then filter paper. Store in amber glass bottles away from light and heat.
3-5 mL (60-100 drops) two to three times daily, diluted in a small amount of water or juice
Two to three times daily
May be used long-term. Reassess periodically.
Not recommended for children due to alcohol content. Use glycerite or milk decoction instead.
Tincture preparation efficiently extracts both the saponins and flavonoid constituents. The moderate alcohol content (45-55%) provides adequate extraction of the steroidal saponins while also capturing the polyphenolic constituents. Tincture is a Western herbal preparation method; in Ayurvedic practice, Shatavari is more traditionally prepared as a powder, milk decoction, or medicated ghee (ghrita). Tinctures are convenient for combining Shatavari with other herbs in formula work. For galactagogue use, capsules or milk decoction are generally preferred over tinctures to avoid alcohol exposure during breastfeeding.
[3]
Glycerite
Strength: 1:5, 60% glycerin / 40% water
Use dried, finely chopped or coarsely powdered Shatavari root. Combine 1 part dried herb with 5 parts menstruum consisting of 60% vegetable glycerin and 40% water. Macerate for 6-8 weeks with regular agitation. Press and filter. The resulting glycerite is sweet-tasting and alcohol-free.
5-10 mL (1-2 teaspoons) two to three times daily
Two to three times daily
May be used long-term
2.5-5 mL (half to one teaspoon) twice daily for children over 3 years, under practitioner guidance
Glycerite is an excellent alcohol-free alternative, particularly appropriate for breastfeeding mothers (galactagogue use), children, and individuals who avoid alcohol. The sweet taste of glycerin complements the sweet taste of Shatavari and improves palatability. Glycerin is a moderate solvent for saponins but less efficient than ethanol; the glycerite may be somewhat less concentrated in saponins than a comparable tincture. Glycerites are popular in clinical practice where alcohol is contraindicated.
[3]
Infusion (Tea)
Strength: 3-5 g dried root per 250 mL hot water
Use 3-5 g of dried, finely cut or powdered Shatavari root per cup (250 mL) of hot water. Pour boiling water over the herb, cover, and steep for 15-20 minutes. Strain and drink. For a stronger preparation, a cold infusion can be made by steeping overnight in room-temperature water.
1-2 cups daily
1-2 times daily
May be used long-term
Half cup daily for children over 6 years
Simple infusion is less efficient than decoction for extracting the steroidal saponins from the fibrous root tissue, but adequately extracts the mucilaginous polysaccharides and some water-soluble saponins. The infusion will be mildly sweet, slightly mucilaginous, and faintly bitter. Best suited for the demulcent and digestive applications (soothing gastritis, urinary irritation) where mucilage extraction is the primary goal. For adaptogenic and reproductive tonic applications requiring maximum saponin extraction, decoction or capsule preparations are preferred.
Standardized Extract
Strength: Varies by manufacturer. Common DER: 4:1 to 10:1. Standardized to 20-40% total saponins (calculated as shatavarins). Some premium extracts standardized to >= 50% saponins.
Commercially prepared standardized extracts of Shatavari root, typically aqueous or hydroalcoholic extracts standardized to minimum saponin content (shatavarins). Products should specify the extraction method, concentration ratio, and standardization marker (e.g., minimum 20% or 40% saponins). Clinical trial preparations have varied, but most use aqueous or hydroalcoholic root extracts.
500-1000 mg standardized extract daily (standardized to 20-40% saponins), in divided doses. Some clinical studies have used higher doses (up to 2 g daily) of less concentrated extracts.
Twice daily with meals
Clinical studies have used 4-12 weeks of supplementation. Long-term use appears safe based on traditional usage.
Not well established in standardized extract form
Standardized extracts provide the most reproducible dosing for clinical applications. The saponin content (measured as total shatavarins) is the primary quality marker. Aqueous extracts capture the full polysaccharide and mucilage content, while hydroalcoholic extracts provide a more concentrated saponin profile. Third-party testing for heavy metals, pesticides, and microbial contaminants is recommended given that Shatavari is a root crop often grown in Indian soils. Product quality varies significantly in the commercial market; consumers should choose products from reputable manufacturers with documented good manufacturing practices.
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Individuals with known allergy to Asparagus racemosus, Asparagus officinalis (common asparagus), or other members of the Asparagaceae family should not use Shatavari products. Allergic reactions may include skin rash, urticaria, and respiratory symptoms. Cross-reactivity between Asparagus species is possible.
The phytoestrogenic activity of Shatavari saponins (estrogen receptor binding) raises a theoretical concern for individuals with estrogen receptor-positive breast cancer, endometriosis, uterine fibroids, or other estrogen-sensitive conditions. While the estrogenic activity is mild (much weaker than endogenous estradiol) and Shatavari has not been shown to promote tumor growth in preclinical models, the potential for estrogen receptor activation in sensitive tissues warrants caution. Patients with current or past ER+ breast cancer should consult their oncologist before using Shatavari.
Due to its cooling, moistening, and tissue-building properties, Shatavari may theoretically aggravate conditions characterized by excess fluid retention, congestion, or Kapha accumulation in Ayurvedic terms. Patients with significant edema, congestive heart failure, or nephrotic syndrome should exercise caution. The heavy, moist quality of Shatavari may exacerbate fluid retention in susceptible individuals.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Estrogen-containing medications (oral contraceptives, HRT) (Estrogens and hormonal therapies) | theoretical | Phytoestrogenic saponins (shatavarins) demonstrate estrogen receptor binding. Concurrent use with exogenous estrogens could theoretically result in additive estrogenic effects, though the phytoestrogenic activity of Shatavari is considerably weaker than pharmaceutical estrogen preparations. |
| Diuretic medications (furosemide, hydrochlorothiazide) (Diuretics) | theoretical | Shatavari has mild diuretic properties. Concurrent use with pharmaceutical diuretics could theoretically result in additive diuretic effects, potentially leading to excessive fluid and electrolyte loss. |
| Lithium (Mood stabilizers) | theoretical | The mild diuretic effect of Shatavari could theoretically alter lithium clearance, potentially affecting serum lithium levels. Changes in sodium and fluid balance can influence lithium pharmacokinetics. |
| Hypoglycemic agents (insulin, metformin, sulfonylureas) (Anti-diabetic medications) | theoretical | Shatavari root extract has demonstrated hypoglycemic activity in animal models, including enhanced insulin secretion and improved insulin sensitivity. Additive blood glucose-lowering effects are theoretically possible when combined with pharmaceutical hypoglycemic agents. |
Pregnancy & Lactation
Pregnancy
likely safe
Lactation
likely safe
PREGNANCY: Shatavari has a long history of traditional use during pregnancy in Ayurvedic medicine as a nourishing, Rasayana tonic believed to support healthy fetal development and prevent miscarriage. The Charaka Samhita and other classical texts recommend Shatavari during pregnancy. Modern safety assessments (Botanical Safety Handbook, AHPA Class 1) do not list pregnancy as a contraindication. No teratogenicity has been observed in animal reproductive studies. However, the phytoestrogenic activity warrants awareness, and no controlled clinical safety studies specific to pregnancy have been conducted. Pregnant women should consult their healthcare provider before use. LACTATION: Shatavari is one of the best-documented herbal galactagogues, with clinical trial evidence (Sharma et al. 1996) demonstrating safety and efficacy in lactating women. No adverse effects in mothers or nursing infants were reported in clinical studies. The WHO Monographs Vol 4 recognize galactagogue use as a clinically supported indication. Shatavari is widely used during breastfeeding in Ayurvedic practice and is considered safe at recommended doses.
Adverse Effects
References
Monograph Sources
- [1] World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 4: Radix Asparagi Racemosi. World Health Organization, Geneva (2009) . ISBN: 978-92-4-154705-5
- [2] Gardner Z, McGuffin M (editors). American Herbal Products Association's Botanical Safety Handbook, 2nd edition. CRC Press, Boca Raton, FL (2013) . ISBN: 978-1-4665-1694-6
- [3] Bopana N, Saxena S. Asparagus racemosus -- ethnopharmacological evaluation and conservation needs. J Ethnopharmacol (2007) ; 110 : 1-15 . DOI: 10.1016/j.jep.2007.01.001 . PMID: 17240097
- [4] Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): a review. Asian Pac J Trop Dis (2013) ; 3 : 242-251 . DOI: 10.1016/S2222-1808(13)60049-3
Clinical Studies
- [5] Sharma S, Ramji S, Kumari S, Bapna JS. Randomized controlled trial of Asparagus racemosus (Shatavari) as a lactogogue in lactational inadequacy. Indian Pediatr (1996) ; 33 : 675-677 . PMID: 8979544
- [6] Pandey SK, Sahay A, Pandey RS, Tripathi YB. Effect of Asparagus racemosus rhizome (Shatavari) on mammary gland and genital organs of pregnant rat. Phytother Res (2005) ; 19 : 721-724 . DOI: 10.1002/ptr.1590 . PMID: 16161030
- [7] Negi JS, Singh P, Joshi GP, Rawat MS, Bisht VK. Chemical constituents of Asparagus. Pharmacogn Rev (2010) ; 4 : 215-220 . DOI: 10.4103/0973-7847.70921 . PMID: 22228964
- [8] Gautam M, Saha S, Bani S, Kaul A, Mishra S, Patil D, Satti NK, Suri KA, Gairola S, Suresh K, Jadhav S, Qazi GN, Patwardhan B. Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity: implications for immunoadjuvant potential. J Ethnopharmacol (2009) ; 121 : 241-247 . DOI: 10.1016/j.jep.2008.10.028 . PMID: 19027067
- [9] Mandal SC, Nandy A, Pal M, Saha BP. Evaluation of antibacterial activity of Asparagus racemosus Willd. root. Phytother Res (2000) ; 14 : 118-119 . DOI: 10.1002/(SICI)1099-1573(200003)14:2<118::AID-PTR580>3.0.CO;2-W . PMID: 10685110
- [10] Kamat JP, Boloor KK, Devasagayam TP, Venkatachalam SR. Antioxidant properties of Asparagus racemosus against damage induced by gamma-radiation in rat liver mitochondria. J Ethnopharmacol (2000) ; 71 : 425-435 . DOI: 10.1016/S0378-8741(00)00176-8 . PMID: 10940579
Traditional Texts
- [11] Charaka (attributed); Sharma PV (translator/editor). Charaka Samhita (text with English translation). Chaukhambha Orientalia, Varanasi, India. Original text ca. 300 BCE - 200 CE; multiple modern translations (200)
- [12] Bhavamishra; Chunekar KC, Pandey GS (editors). Bhavaprakasha Nighantu (Indian Materia Medica). Chaukhambha Bharti Academy, Varanasi, India. Original text ca. 16th century CE (1550)
Pharmacopeias & Reviews
- [13] Government of India, Department of AYUSH. The Ayurvedic Pharmacopoeia of India, Part I, Volume I: Shatavari (Asparagus racemosus Willd.). Government of India, Ministry of Health and Family Welfare, Department of AYUSH, New Delhi (2001)
- [14] Indian Pharmacopoeia Commission. Indian Pharmacopoeia 2014: Shatavari. Indian Pharmacopoeia Commission, Ghaziabad, India (2014)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.